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Abstract
Kidney and cardiovascular disease are widespread among populations with high preva-
lence of diabetes, such as American Indians participating in the Strong Heart Study (SHS).
Studying these conditions simultaneously in longitudinal studies is challenging, because
the morbidity and mortality associated with these diseases result in missing data, and these
data are likely not missing at random. When such data are merely excluded, study findings
may be compromised. In this article, a subset of 2264 participants with complete renal func-
tion data from Strong Heart Exams 1 (1989–1991), 2 (1993–1995), and 3 (1998–1999) was
used to examine the performance of five methods used to impute missing data: listwise
deletion, mean of serial measures, adjacent value, multiple imputation, and pattern-mixture.
Three missing at randommodels and one non-missing at randommodel were used to com-
pare the performance of the imputation techniques on randomly and non-randomly missing
data. The pattern-mixture method was found to perform best for imputing renal function
data that were not missing at random. Determining whether data are missing at random or
not can help in choosing the imputation method that will provide the most accurate results.
Introduction
Missing medical data are common in epidemiologic studies. This problem is exacerbated in
longitudinal studies, where missing data increase over time, sometimes compromising results
[1]. Because it can be difficult or impossible to verify whether data are missing at random
(MAR) or are related to the outcome of interest [2], some studies ignore missing data by drop-
ping missing observations from the data set. Although such listwise deletion (LD) is sometimes
the simplest or only way to conduct an analysis, this method can lead to inaccurate conclu-
sions. In such cases, investigators impute missing values to generate complete data for a key
variable or to maximize power for an intent-to-treat study. The objective of this article is to aid
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researchers in selecting the imputation method that will provide the most valid estimates by
simulating the nature of missing data in the Strong Heart Study (SHS) and testing differing
remedial measures. In this article, the importance of understanding the reason missing values
may arise in the data is highlighted, and the measures most appropriate for each context are
discussed.
Missing data can be classified in one of three ways: missing completely at random (MCAR),
missing at random (MAR), and not missing at random (NMAR). When the probability that a
value is missing is statistically independent of its own hidden value and the value of all other
variables, then the data are considered MCAR. Because of this independence, the bias resulting
from the missing data is mitigated, but because most software will automatically apply listwise
deletion (LD) to observations with missing data, reduction in power and information loss can
be substantial. When the probability that a value is missing is correlated with the values of
other variables, but is independent of its own hidden value, then the data are considered MAR.
Finally, if the probability that a value is missing is correlated with its own value, then the data
are considered NMAR. Understanding why data are missing in a data set is an important factor
in choosing the remedial measure to be used for imputing the missing data. While general
rules regarding imputation method applications apply, the appropriateness of any method is
largely determined in each specific case based on numerous factors, including the nature of the
missing data. In this article, we will investigate this issue using data from the SHS, a longitudi-
nal study of American Indians.
Kidney disease is widespread among populations with high prevalence of diabetes. Individu-
als with chronic kidney disease (CKD) are at elevated risk for all-cause and cardiovascular
disease (CVD) mortality [3–9], and an adverse CVD risk factor profile is associated with
declining kidney function [10]. Occurrence of diminishing renal function along with worsen-
ing CVD risk factors is a phenomenon challenging to longitudinal study of these diseases in
populations, such as American Indians, in which both conditions are common. The morbidity
and mortality associated with these diseases result in large amounts of missing data, and these
data are likely NMAR.
The SHS population has high rates of CVD, diabetes, and renal disease. Data on serum cre-
atinine (Scr), a screening test for kidney function, are missing at varying rates across the three
phases of the SHS study, in some cases probably for non-random reasons. Therefore, after
selecting a subset of patients with full longitudinal data, we simulated missing data using four
different methods. We then applied five different remedial measures to deal with the missing
values. A Cox survival regression was executed on the full data set, predicting time to a hard
atherosclerotic cardiovascular disease event based on Scr. A Cox regression model was then
performed on the imputed data sets, and the hazard ratios for Scr values at each exam were
compared with the hazard ratios of the first. We hypothesized that the pattern-mixture (PM)
method would generate hazard ratios closest to those in the complete set.
Methods
Study population
The SHS was initiated in 1988 to investigate CVD and its risk factors in American Indians
from 13 tribes in Arizona, Oklahoma, and North and South Dakota. The SHS design and meth-
ods have been published [11–12]. The SHS was approved by the Oklahoma Center Indian
Health Service institutional review board (IRB), the Dakota Center Indian Health Service IRB,
the Arizona Center Indian Health Service IRB, and the MedStar Health Research Institute IRB.
In addition, this study was approved by the American Indian communities. All data were anon-
ymized and de-identified before the analyses. This cohort of 4549 American Indians includes
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men and women ages 45–74 years seen at the first (1989–1991), second (1993–1995), and third
(1998–1999) exams. Participants receiving dialysis or who had a kidney transplant were elimi-
nated from the data set. Of the 4549 SHS participants at baseline, 3605 were alive at Exam 3,
and 2219 (62%) were women. A subset of 2264 participants with complete renal function data
at all three exams was used for the current analyses.
Renal function measures
Scr was assayed by a single core laboratory using automated alkaline picrate rate methodology
[12]. Urinary creatinine was measured at all three exams [10,13].
Cardiovascular and diabetes surveillance
CVD surveillance for nonfatal and fatal clinical events occurred throughout the follow up and
is complete through December 31, 2003 [14]. Criteria used to define definite fatal myocardial
infarction, stroke, coronary heart disease, and nonfatal CVD have been published [15], as have
methods for ascertaining incident CVD events [13, 16–17]. Incident diabetes was identified by
self-report, use of hypoglycemic agents, or fasting glucose126 mg/dl [18].
Creation of missing data models
The complete SHS data set included age, gender, history of diabetes, CVD status, and three
serial measures of Scr. The outcome variable of interest was CVD. Four models with randomly
(Models 1–3) and non-randomly (Model 4) missing data were created from the complete data
set using the algorithms described below.
Model 1, Base data with MAR data. In Model 1, the data were missing at random. This
model was created from the complete data set.
Model 2, Autoregressive MAR data. LetM be the matrix that represents the missing data,
so a value of 0 indicates that the observation exists and 1 indicates that it is missing. Then con-
sider the Yp matrix, which consists of Scr measurements on the 3605 subjects:
Yp ¼
Scr11 Scr12 Scr13
..
.
Scrn1 Scrn2 Scrnk
2
6664
3
7775
LetMp be the matrix of missing data associated with Yp. We proposed the following autore-
gressive MAR generating mechanism: P(Mp[i,j] = 1) = f(Mp[i,j − 1]), (Model 1); whereMp[i,j]
corresponds to the entry in the row I and column j inM. The probability that a subject has a
missing value at stage j depends on whether the subject had a missing value in stage j –1. Thus,
missing Scr data at Exam 3 are not independent of missing Scr data at Exam 2 and any algo-
rithm generating MAR data should account for that, even though missing Scr data at Exam 2
are independent of missing data at Exam 1. When fitting an autoregressive model of the form
P(M p[i,2] = 1) = α + β × 1{M p[i,1] = 1}, the slope coefficient has a t-value of 1.48 and thus is
not significant at the 10% alpha level. Missing values at Exam 1 were selected at random with a
Bernouli random generator.
Model 3, Autoregressive MAR data augmented with gender and age. For gender, let X
be a binary vector denoting gender, with women having an entry of 0 and men an entry of 1.
Women and men appear to have different rates of missing data. At Exams 2 and 3, women
have significantly lower rates of missing data than men (all P values<0.01). At Exam 1, the sig-
nificant difference between genders was not observed (p>0.05).
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Thus, we proposed the following algorithm to generate values for Model 3 P(M p[i,j] = 1) =
α + βgX + βm1{M p[i,j − 1] = 1}, where 1{M p[i,j − 1] = 1} is an indicator function with a value
of 1 when Scr is missing in the previous exam. We did not apply this model to Exam 1 missing
data, because no significant difference between genders was observed. The following general-
ized linear models with a binary response variable for the rate of missing data and an identity
link were fitted using the Broyden-Fletcher-Goldfarb-Shanno (BFGS) method [19]. The BFGS
method solves an unconstrained nonlinear optimization problem using gradient descent. It is a
member of a broad class of hill-climbing optimization techniques. We applied it to predict the
rate of missing data at Exams 2 and 3 as follows:
Exam 2: P(M p[i,2] = 1) = .089+.036X; gender coefficient t-value is 4.2;
Exam 3: P(M p[i,3] = 1) = .082+.029X + .353×1{M p[i,2] = 1}; gender coefficient has a t sta-
tistic of 3.44, while the autoregressive coefficient has a t-value of 21.75.
Age is a variable that influences the rate of missing observations. The elderly may experi-
ence difficulty getting to the testing site, may move to retirement homes or hospices, or may
die, thus missing exams. The relationship between the probability of missing data and partici-
pant age at Exams 1 and 2 was weak and unexpectedly U-shaped, while the probability of a
relationship between participant age and missing data at Exam 3 was a more pronounced U-
shape. One explanation is that younger participants may drop out more frequently because of
employment or relative lack of concern for personal health. The following formulas define
Model 3, using age (denoted by Y) and previous missing data as explanatory variables (all of
the coefficients were significant, thus we excluded the t-values).
Exam 2: PðMp½i; 2 ¼ 1Þ ¼ 1:93þ :030 Y  :461
ﬃﬃﬃ
Y
p
,
Exam3: P(M p[i,3] = 1) = 3.62 + .065×Y − .953×ln(Y) + .355×1{M p[i,2] = 1}.
Finally, including all the explanatory factors, we propose Model 3 with gender and age as a
MAR algorithm:
Exam 2: PðMp½i; 2 ¼ 1Þ ¼ 1:80þ :035 X þ :028 Y  :44
ﬃﬃﬃ
Y
p
,
Exam 3: P(M p[i,3] = 1) = 3.22 + .030×X + .059×Y − .863×ln(Y) + .353×1{M p[i,2] = 1}.
Adding gender does not dramatically alter the age and the previous missing data coefficients
from this model, yet the likelihood-ratio tests show that adding age decreases residual deviance
in Exams 2 and 3 significantly. In this analysis, Model 3 with gender and age was the one used
to test the performance of the different imputation methods on autoregressive missing data
augmented with covariates.
Model 4. Empirical NMAR data. Similar to the empirical models for MAR data (Models
1–3), the following model estimates two potential NMARmechanisms for our complete Scr
data set. The algorithm used was developed by Troxel et al. [20]. This algorithm assumes that
data are multivariate normal and f(Yt|Yt-1,Yt-2,. . .) = f(Yt|Yt-1).
Let πi denote the probability that the observation is missing at stage i. We then fit the follow-
ing model for women and men separately: logit(πi) = α+βyij ; where yij was the Scr value in
phase i for subject j. We estimated the parameters above using the Likelihood function
described by Troxel et al. Using the S-Plus library MASS and the function OPTIM [21] to max-
imize the likelihood, we obtained standard errors of the estimates by retaining the Hessian
matrix, inverting it, and taking the square root of the diagonal.
Empirical NMAR data model for women and men. The algorithm used in this model
was developed by Troxel et al. [20], which assumes that the data are multivariate normal and f
(Yt|Yt-1,Yt-2,. . .) = f(Yt|Yt-1).
The Troxel method: Let πi denote the probability that the observation is missing at stage
i. We will then fit the following model for women and men separately: logit(πi) = α+βyij ;
where yij is the Scr value in phase i for subject j. We will estimate the parameters above by
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using the Likelihood function [20]. The parameter estimates and their standard errors (in
parentheses) were obtained for women and men for the equation above.
For women, the parameter estimates were significant, but for men, the intercept was signifi-
cant. At Exam 2, the β estimate was not significant at the 5% significance level, and at Exam 3
it was marginally significant at that level. The probability of missing data is, therefore, less
dependent on Scr values for men than for women.
The fitted missing data probability functions were used to generate the last missing value
mechanism. Although the fitted NMAR model was not significant for men at Exam 2, it is
important to examine the effects of missing data on the outcome measures.
The four models are summarized below:
Model 1: Base data with MAR data
Model 2: Autoregressive MAR data
Model 3: Autoregressive MAR data +gender + age
Model 4. Empirical NMAR data using the Troxel et al. algorithm.
Missing data were then replaced in each model using each of five imputation methods (LD,
mean of serial measures, adjacent value [AV], multiple imputation [MI], and PM) to compare the
efficacy of these methods in providing Scr values for randomly and non-randomly missing data.
Imputation methods
The five imputation methods used to fill in missing Scr values are described:
&. Listwise deletion (LD), where observations with missing data are dropped. This method
should only be used with MAR data, as it can generate biased data. This method reduces
the sample size.
&. Imputation using the mean (mean of serial measures), where the overall variable mean is
used to impute cross-sectional data. Use of this method is limited to continuous data. In
this study, this method was used with mean Scr values from the corresponding exam to
impute missing Scr values.
&. AV, where missing data are replaced by using the most adjacent value. In this study, these
came from either the previous or subsequent exam. This method is used to impute miss-
ing longitudinal data. In this study, it was assumed that no change in kidney function
occurred after a clinical or sub-clinical event. This method may bias results because of
early dropouts who have less favorable measures [22].
&. MI, where multiple single imputations are carried out simultaneously on the incomplete
data set to obtain a fitted model with differing parameter estimates. Missing data are
assumed to be MAR.
&. PM [23–25], where assumptions are applied to the missing data using MI techniques. This
method specifies thresholds to restrict the imputed values. The assumption in this study
was that patients with lower Scr values were more likely to have missing values. Therefore,
the restricting upper-bound thresholds selected were the 10th, 25th, and 50th percentiles of
the predicted Scr values.
Statistical Analysis
Baseline characteristics were provided for the SHS participants with complete renal data.
Means with corresponding 95% confidence intervals (CIs) of Scr were generated by each impu-
tation method and compared with the complete data set for each of the generated missing data
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models. Cox proportional hazard models were used to examine associations between CVD risk
and imputed Scr in the four models. Hazard ratios (HRs) and 95% CIs were calculated and
adjusted for age, gender, and diabetes status.
The five imputation methods were compared to determine a) differences in distributions
between the imputed data sets and the complete data set as measured by the mean and 95%
CIs, b) discrepancies in estimates of the adjusted HRs of incident CVD and limits of the 95%
CIs for each imputed data set versus the complete set at each exam using a non-time-depen-
dent covariate Cox proportional model, and c) the significance of the models examined in each
imputed data set compared with the complete data set using a time-dependent covariate Cox
proportional model. The method that provided HR estimates closest to those generated by the
complete data set was considered to perform the best.
Results
Among the entire SHS cohort of 4549 subjects, the percentage of missing data at Exams 1, 2,
and 3 was 3.8%, 22.3%, and 32.5%, respectively. The generated rates of missing Scr data for the
2264 participants in Models 1, 2, 3, and 4 were approximately 20%, 30%, and 40% at Exams 1,
2, and 3, respectively.
In the 2264 SHS participants with complete Scr data for all three exams, mean baseline Scr
was 0.88 mg/ml (standard deviation [SD] = 0.3 mg/ml), and mean age was 54.9 years (SD = 7.4
years). Sixty-four percent of participants were female, 37.3% had diabetes, and 4.6% had preva-
lent CVD. During a median 10 years of follow up (Exam 1 to December 31, 2003), 447 (19.7%)
experienced a CVD event (Table 1).
The distribution of Scr in the four models is presented for each of the five imputation meth-
ods (Table 2). Models 1, 2, and 3 represent MAR data, while Model 4 represents the NMAR
data. All the imputation methods underestimated the mean, especially for Model 4 at Exam 3,
in which the rate of missing data was approximately 40%. LD performed slightly better than
the other imputation methods in Models 1, 2, and 3, but underestimated the mean and SD in
Model 4 at Exams 2 and 3. Imputation using the mean also performed well in Models 1, 2, and
3 but, like the LD method, underestimated the mean and SD in Model 4 at Exams 2 and 3.
Imputation using the AV did not perform as well as LD in Models 1, 2, and 3, but it was slightly
better in not underestimating the mean and SD in Model 4 at Exams 2 and 3 than the LD and
MI methods were. Imputation using MI overestimated the mean in Models 1, 2, and 3 at Exam
3 and underestimated the mean and SD in Model 4 at Exam 3. The PMmethod at the 10th,
25th, and 50th percentiles of the Scr data estimated the mean in Model 4 at Exams 2 and 3
across all levels of percentiles better than the other imputation methods did. Additionally, the
higher percentiles seemed to provide estimates closer to those made with the complete data set.
Table 1. Baseline Characteristics of Strong Heart Study Participants with Complete Scr Data at All
Three Exams (N = 2,264).
Variable N Mean (SD)
Scr 2,264 0.88±0.25
Age 2,264 54.9±7.4
Female 1451 64.1%
Diabetes 845 37.3%
Prevalent CVD 104 4.6%
Incident CVD by 2003 447 19.7%
Abbreviations: CVD = cardiovascular disease; Scr = serum creatinine.
doi:10.1371/journal.pone.0138923.t001
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Table 2. Mean and SD of Scr Values Stratified by Imputation Method andModel.
Exam 1 Complete Data Scr mean (sd): 0.88 (0.25)
Missing Data Generation Method
Imputation
method
Data with Randomly Missing
Values (Model 1)
Autoregressive Missing
(Model 2)
Autoregressive w/ Gender and Age
(Model 3)
Troxel Algorithm (NMAR
Data; Model 4)
LD 0.87 (0.26) 0.87 (0.18) 0.88 (0.27) 0.88 (0.27)
Mean 0.87 (0.24) 0.87 (0.16) 0.88 (0.24) 0.88 (0.24)
AV 0.87 (0.26) 0.87 (0.18) 0.88 (0.27) 0.88 (0.27)
MI 0.87 (0.25) 0.87 (0.17) 0.87 (0.25) 0.88 (0.25)
PM (10th
percentile)
0.88 (0.26) 0.87 (0.17) 0.89 (0.25) 0.88 (0.25)
PM (25th
percentile)
0.88 (0.25) 0.88 (0.17) 0.89 (0.25) 0.89 (0.26)
PM (50th
percentile)
0.88 (0.26) 0.88 (0.17) 0.89 (0.25) 0.89 (0.26)
Exam 2 Complete Data Scr mean (sd): 0.90 (0.44)
Missing Data Generation Method
Imputation
method
Data with Randomly Missing
Values (Model 1)
Autoregressive Missing
(Model 2)
Autoregressive w/ Gender and Age
(Model 3)
Troxel Algorithm (NMAR
Data; Model 4)
LD 0.90 (0.47) 0.89 (0.35) 0.90 (0.45) 0.83 (0.19)
Mean 0.90 (0.39) 0.89 (0.29) 0.90 (0.38) 0.83 (0.16)
AV 0.89 (0.43) 0.89 (0.32) 0.89 (0.41) 0.86 (0.28)
MI 0.91 (0.45) 0.89 (0.31) 0.91 (0.39) 0.84 (0.19)
PM (10th
percentile)
0.95 (0.45) 0.93 (0.32) 0.95 (0.41) 0.86 (0.19)
PM (25th
percentile)
0.97 (0.46) 0.95 (0.32) 0.97 (0.41) 0.88 (0.19)
PM (50th
percentile)
0.98 (0.46) 0.96 (0.33) 0.99 (0.42) 0.90 (0.21)
Exam 3 Complete Data Scr mean (sd): 0.94 (0.88)
Missing Data Generation Method
Imputation
method
Data with Randomly Missing
Values (Model 1)
Autoregressive Missing
(Model 2)
Autoregressive w/ Gender and Age
(Model 3)
Troxel Algorithm (NMAR
Data; Model 4)
LD 0.95 (0.94) 0.94 (0.85) 0.93 (0.85) 0.76 (0.17)
Mean 0.95 (0.73) 0.94 (0.67) 0.93 (0.67) 0.76 (0.13)
AV 0.93 (0.81) 0.93 (0.72) 0.92 (0.74) 0.82 (0.26)
MI 1.03 (0.86) 1.00 (0.76) 1.00 (0.77) 0.79 (0.17)
PM (10th
percentile)
1.14 (0.89) 1.09 (0.79) 1.12 (0.83) 0.81 (0.17)
PM (25th
percentile)
1.16 (0.89) 1.12 (0.80) 1.13 (0.82) 0.83 (0.17)
PM (50th
percentile)
1.19 (0.91) 1.13 (0.82) 1.16 (0.84) 0.85 (0.19)
Abbreviations: AV = imputation using adjacent value; LD = listwise deletion; Mean = imputation using the mean; MI = multiple imputation; NMAR = not
missing at random; PM = pattern mixture.
Model 1 = data with randomly missing values
Model 2 = autoregressive missing
Model 3 = autoregressive +gender + age
Model 4 = NMAR data.
doi:10.1371/journal.pone.0138923.t002
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The imputation techniques also were compared with respect to adjusted HRs and 95% CIs
for CVD risk at Exams 1, 2, and 3 across the four models (Table 3). The complete case data
showed significant relations between Scr and CVD risk only at Exam 2. Performance of the
imputation methods varied with the different data sets. At Exam 1, all the imputation methods
gave similar estimates of HRs. All the imputation methods showed significant relations
between imputed Scr and CVD risk in Model 2 at Exam I. At Exam 2, all the imputation meth-
ods yielded significant results between the imputed Scr values and CVD risk in Models 2 and 3.
The biggest difference in the results was found in Model 4 at Exam 2. A non-significant protec-
tive effect (i.e., HRs<1) was found in Model 4 using the LD and mean imputation methods. At
Exam 3, all of the imputation methods yielded similar results in Models 1, 2, and 3, but overes-
timated the hazard ratio in Model 4, compared with the complete data set. However, the esti-
mated HRs using the PM and AV methods were closer to the HRs from the complete data set.
In a time-dependent covariate Cox model (Table 4), in which we did not break down the
data into the three exam periods, the adjusted HRs with 95% CIs for CVD risk were stronger
for all the imputation methods in Model 4, compared with the complete data set. In Model 4,
all the imputation methods yielded significant results, but PM and AV performed better than
the others.
Conclusions
We developed four models of missing data, generated from a complete data set, and modeled
the missing Scr data across the three SHS examinations. Results varied depending on the impu-
tation technique. For the MAR model with 20–40% missing data, all the imputation methods
performed similarly. For the NMAR model, AV performed almost as well as PM, possibly
because renal dysfunction progresses over time, so using AV may generate results close to
those generated with the complete data set. Using different imputation methods to estimate
missing Scr values provided varied results, with some methods overestimating Scr and others
underestimating it. No one method was superior to the others across all models and exams.
This finding is reasonable because we used two empirical mechanisms to generate patterns
of missing data (MAR and NMAR), and because Scr is a protein that changes over time. The
PMmethod performed better in Model 4 across all exams, providing hazard ratio estimates
closest to those generated with the complete data set. The PMmethod outperformed the others
on both the mean estimation and the hazard ratio, providing estimates that were closest to
those made with the complete data set. Finally, these findings suggest that the PMmethod for
imputing missing Scr values performed better for the data not MAR. Most imputation methods
work well when data are MAR. For data not MAR, the PMmethod performed best for imput-
ing renal function data in this large study of progressive CKD and CVD.
These findings reinforce the point that remedial methods chosen to manage missing values
are dependent on the specific case, the nature of the missing data, the nature of the random
variable, and the correlation between the missing data and the values in the data. In this case,
because of the reasonable assumption that the missing data primarily arose from deterioration
in kidney function and resulting mortality (i.e., not MAR), the PMmethod addressed the miss-
ing value problem the best. The assumption of the cause of mortality is as important as the
other factors in choosing a remedial method. If mortality is a potential cause of missing values
and is not correlated with the variable to be imputed, then the missing values are more appro-
priately treated as MAR. In that case, methods such as MI or auto-regression are more
appropriate.
Further issues may arise regarding the specification of the model used for the imputation.
The researcher must exercise judgment regarding whether all factors and covariates that affect
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Table 3. Adjusted Hazard RatiosWith 95%Confidence Intervals for Cardiovascular Disease Risk.
Exam 1 Complete Data Scr HR (95% CI): 1.15 (0.87–1.53)
Missing Data Generation Method
Imputation
method
Data with Randomly Missing
Values(Model 1)
Autoregressive Missing
(Model 2)
Autoregressive w/ Gender and Age
(Model 3)
Troxel Algorithm (NMAR
Data; Model 4)
LD 1.05 (0.73–1.51) 2.21 (1.31–3.67) 1.16 (0.86–1.55) 1.17 (0.88–1.55)
Mean 1.06 (0.75–1.51) 2.19 (1.31–3.67) 1.13 (0.83–1.54) 1.16 (0.87–1.54)
AV 1.05 (0.73–1.51) 2.21 (1.30–3.76) 1.16 (0.86–1.55) 1.17 (0.88–1.55)
MI 1.11 (0.82–1.51) 1.98 (1.18–3.33) 1.16 (0.87–1.54) 1.15 (0.87–1.54)
PM (10th
percentile)
1.08 (0.78–1.49) 2.05 (1.23–3.41) 1.13 (0.84–1.53) 1.16 (0.86–1.56)
PM (25th
percentile)
1.09 (0.80–1.49) 2.11 (1.26–3.52) 1.15 (0.85–1.56) 1.14 (0.85–1.54)
PM (50th
percentile)
1.10 (0.80–1.51) 2.21 (1.30–3.75) 1.17 (0.88–1.55) 1.19 (0.91–1.55)
Exam 2 Complete Data Scr HR (95% CI): 1.17 (1.01–1.35)
Missing Data Generation Method
Imputation
method
Data with Randomly Missing
Values (Model 1)
Autoregressive Missing
(Model 2)
Autoregressive w/ Gender and Age
(Model 3)
Troxel Algorithm(NMAR Data;
Model 4)
LD 1.14 (0.96–1.35) 1.37 (1.11–1.68) 1.23 (1.08–1.41) 0.66 (0.32–1.47)
Mean 1.14 (0.97–1.35) 1.34 (1.09–1.65) 1.23 (1.08–1.40) 0.69 (0.32–1.35)
AV 1.12 (0.94–1.33) 1.40 (1.16–1.69) 1.23 (1.09–1.40) 1.09 (0.76–1.55)
MI 1.10 (0.92–1.31) 1.34 (1.08–1.66) 1.22 (1.06–1.40) 1.01 (0.53–1.95)
PM (10th
percentile)
1.07 (0.9–1.30) 1.38 (1.14–1.67) 1.24 (1.09–1.40) 1.19 (0.59–2.42)
PM (25th
percentile)
1.07 (0.88–1.29) 1.40 (1.16–1.68) 1.23 (1.08–1.40) 1.05 (0.55–1.98)
PM (50th
percentile)
1.09 (0.91–1.31) 1.40 (1.15–1.70) 1.23 (1.08–1.40) 1.16 (0.66–2.02)
Exam 3 Complete Data Scr HR (95% CI): 1.10 (0.97–1.25)
Missing Data Generation Method
Imputation
method
Data with Randomly Missing
Values (Model 1)
Autoregressive Missing
(Model 2)
Autoregressive w/ Gender and Age
(Model 3)
Troxel Algorithm (NMAR
Data; Model 4)
LD 1.09 (0.94–1.26) 1.12 (0.95–1.31) 1.07 (0.89–1.29) 1.79 (0.51–6.23)
Mean 1.10 (0.94–1.27) 1.10 (0.94–1.28) 1.07 (0.90–1.28) 1.76 (0.54–5.78)
AV 1.08 (0.93–1.25) 1.13 (0.98–1.30) 1.12 (0.96–1.30) 1.39 (0.93–2.06)
MI 1.04 (0.89–1.21) 1.13 (0.99–1.30) 1.11 (0.97–1.27) 1.87 (0.70–4.97)
PM (10th
percentile)
1.00 (0.8–1.20) 1.11 (0.95–1.31) 1.11 (0.96–1.28) 1.52 (0.62–3.76)
PM (25th
percentile)
1.02 (0.86–1.20) 1.13 (0.98–1.31) 1.12 (0.98–1.27) 1.38 (0.54–3.54)
PM (50th
percentile)
1.01 (0.86–1.19) 1.13 (0.98–1.30) 1.11 (0.98–1.27) 1.37 (0.58–3.26)
& Cox proportional regression models adjusted for age, gender, and diabetes.
*Signiﬁcant at 5%.
Abbreviations: LD = listwise deletion; Mean = imputation using the mean; AV = imputation using adjacent value; MI = multiple imputation; NMAR = not
missing at random; PM = pattern mixture.
Complete Data: data with no missing values
Model 1: data with randomly missing values
Model 2: autoregressive missing
Model 3: autoregressive +gender + age
Model 4: NMAR data.
doi:10.1371/journal.pone.0138923.t003
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the variable to be imputed are controlled for in the regression model. If all the factors are not
available, then the researcher must decide whether to impute them based on partial informa-
tion or use listwise deletion.
This study is strengthened by its large cohort, which allowed us to model missing data, use
several covariates to explain the missing data, and generate several types of missing data. This
work provides a basis for handling missing data by identifying whether the data are MAR or
NMAR.
When the missing data mechanism is not accounted for when performing statistical analy-
ses, the resulting estimates can be misleading. The type and extent of missing data should be
considered when choosing an imputation technique. Taking steps to determine whether data
are MAR or are missing because of some mechanism can help investigators select the best
imputation method for their data.
Acknowledgments
We gratefully acknowledge Rachel Schaperow, MedStar Health Research Institute, for editing
the manuscript.
Disclaimer: The opinions expressed in this paper are those of the authors and do not neces-
sarily reflect the views of the Indian Health Service.
Author Contributions
Conceived and designed the experiments: NS BVH JGU. Performed the experiments: NS EV
HW. Analyzed the data: EV HW. Contributed reagents/materials/analysis tools: NS EV HW
JGU. Wrote the paper: NS EV HW BVHWW ETL JGU SAY.
References
1. Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials 2000; 21(3):167–
189.
2. Kang T, Kraft P, GaudermanWJ, Thomas D; FraminghamHeart Study. Multiple imputation methods
for longitudinal blood pressure measurements from the Framingham Heart Study. BMCGenet 2003;
44(Suppl1):S43.
Table 4. Adjusted Hazard RatiosWith 95%CI for CVD Risk: Time-Dependent Cox Model.
Model Complete
Data
LD Mean AV MI PM (10th
percentile)
PM (25th
percentile)
PM (50th
percentile)
1 1.04(0.95–
1.15)
1.03(0.92–
1.15)
1.02(0.90–
1.15)
1.03(0.92–
1.15)
0.92(0.73–
1.16)
0.83(0.71–0.97) 0.82(0.68–0.98) 0.81(0.68–0.96)
2 1.04(0.95–
1.15)
1.05(0.92–
1.18)
1.02(0.89–
1.16)
1.07(0.96–
1.20)
1.00(0.88–
1.13)
0.92(0.79–1.08) 0.90(0.78–1.04) 0.91(0.77–1.06)
3 1.04(0.95–
1.15)
1.04(0.92–
1.18)
1.04(0.91–
1.18)
1.07(0.96–
1.20)
1.01(0.90–
1.14)
0.93(0.82–1.06) 0.91(0.79–1.04) 0.91(0.79–1.05)
4 1.04(0.95–
1.15)
6.98(3.57–
13.66)*
13.35(7.36–
24.21)*
1.45(1.18–
1.79)*
3.26(1.86–
5.71)*
2.76(1.69–4.50)* 2.86(1.50–5.48)* 2.50(1.52–4.12)*
Abbreviations: LD = listwise deletion; Mean = imputation using the mean; AV = imputation using adjacent value; MI = multiple imputation; PM = pattern
mixture.
Complete Data: data with no missing values.
Model 1: data with randomly missing values
Model 2: autoregressive missing
Model 3: autoregressive +gender + age
Model 4: NMAR data.
doi:10.1371/journal.pone.0138923.t004
Imputing Missing Renal Function Data
PLOS ONE | DOI:10.1371/journal.pone.0138923 September 28, 2015 10 / 11
3. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary inter-
vention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103(5):368–375.
4. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine
and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J
Am Coll Cardiol 2003; 42(9):1535–1543.
5. Januzzi JL Jr, Snapinn SM, DiBattiste PM, Jang IK, Theroux P. Benefits and safety of tirofiban among
acute coronary syndrome patients with mild to moderate renal insufficiency: Results from the Platelet
Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and
Symptoms (Prism-Plus) trial. Circulation 2002; 105(20):2361–2366.
6. Newby LK, Bhapkar MV, White HD, Topol EJ, Dougherty FC, Harrington RA, et al. Predictors of 90-day
outcome in patients stabilized after acute coronary syndromes. Eur Heart J 2003; 24(2):172–181.
7. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent
renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use
of glycoproteinIIb/IIIa inhibitors. J Am Coll Cardiol 2003; 41(5):718–724.
8. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implica-
tions of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;
106(8):974–980.
9. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revas-
cularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J
Cardiol 2003; 92(5):509–514.
10. Anavekar NS, Pfeffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int 2004; 66(Suppl
92):S11–S15.
11. Lee ET, Welty TK, Fabsitz R, Le NA, Oopik AJ, Cucchiara AJ, et al. The Strong Heart Study. A study of
cardiovascular disease in American Indians: Design and methods. Am J Epidemiol 1990; 132(6):1141–
1155.
12. Howard BV, Welty TK, Fabsitz RR, Cowan LD, Oopik AJ, Le NA, et al. Risk factors for coronary heart
disease in diabetic and nondiabetic Native Americans. The Strong Heart Study. Diabetes 1992; 41
(Suppl 2):4–11.
13. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, et al. Sustained reduction
of proteinuria in Type 2 (non-insulin dependent) diabetes following diet-induced reduction of hypergly-
cemia. Diabetologia 1984; 26(2):127–133.
14. Lee ET, Cowan LD, HowardWJ, Sievers M, HowardWJ, Oopik A, et al. All-cause mortality and cardio-
vascular disease mortality in three American Indian populations aged 45–74 years, 1984–88. The
Strong Heart Study. Am J Epidemiol 1998: 147(11);995–1008.
15. Lee ET, Devereux RB, Yeh J-L, WaungW, Go O. Selected mortality rates in the Strong Heart Study
population. J Investig Med 1995; 43:510A.
16. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who
are we missing? Nephrol, Dialy, Transplant 2001; 16(5):1042–1046.
17. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, et al. Rising tide of cardiovascular
disease in American Indians: the Strong Heart Study. Circulation 1999; 99(18):2389–2395.
18. Resnick H E, Jones K, Ruotolo G, Jain AK, Henderson J, LuW, Howard BV, et al. Insulin resistance,
the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians:
The Strong Heart Study. Diabetes Care 2003; 26(3):861–867.
19. Gill PE, MurrayW, Wright MH. Practical Optimization. London: Academic Press, Inc., 1981.
20. Troxel AB, Harrington DP, Lipsitz SR. Analysis of longitudinal data with non-ignorable non-monotone
missing values. Applied Statistics 1998; 47(3): 425–438.
21. http://cran.r-project.org/web/packages/MASS/MASS.pdf.
22. Houck P, Mazumdar S, Reynolds CF III. MACRO FOR LOCF: Comparison of results with PROC
Mixed. University of Pittsburgh Medical Center.
23. http://pharmasug.org/proceedings/2011/SP/PharmaSUG-2011-SP04.pdf. Accessed August 5, 2015.
24. Demirtas H, Schafer JL. On the performance of random-coefficient pattern-mixture models for non-
ignorable drop-out. Statistics in Medicine 2003; 22:1553–2575.
25. Molenberghs G, Michiels B, Kenward MG, Diggle PJ. Missing data mechanisms and pattern-mixture
models. Statistica Neerlandica 1998; 52:153–161.
Imputing Missing Renal Function Data
PLOS ONE | DOI:10.1371/journal.pone.0138923 September 28, 2015 11 / 11
